vs
Doximity, Inc.（DOCS）与Sotera Health Co（SHC）财务数据对比。点击上方公司名可切换其他公司
Sotera Health Co的季度营收约是Doximity, Inc.的1.6倍（$303.4M vs $185.1M），Doximity, Inc.净利率更高（33.3% vs 11.5%，领先21.8%），Doximity, Inc.同比增速更快（9.8% vs 4.6%），过去两年Doximity, Inc.的营收复合增速更高（25.2% vs 10.6%）
Doximity Inc成立于2010年，是面向医疗专业人士的线上社交服务平台，为平台会员提供精选医疗资讯、远程医疗工具，以及病例协作相关功能，助力医疗从业者高效交流信息、开展诊疗相关工作。
Sotera Health Co是全球领先的医疗安全解决方案提供商，面向医疗器械厂商、制药企业、食品及消费品公司提供灭菌服务、实验室分析检测与合规咨询支持，帮助客户满足监管要求，保障上市产品的使用安全。
DOCS vs SHC — 直观对比
营收规模更大
SHC
是对方的1.6倍
$185.1M
营收增速更快
DOCS
高出5.2%
4.6%
净利率更高
DOCS
高出21.8%
11.5%
两年增速更快
DOCS
近两年复合增速
10.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $185.1M | $303.4M |
| 净利润 | $61.6M | $34.8M |
| 毛利率 | 89.9% | 54.7% |
| 营业利润率 | 38.9% | 23.2% |
| 净利率 | 33.3% | 11.5% |
| 营收同比 | 9.8% | 4.6% |
| 净利润同比 | -18.1% | 182.8% |
| 每股收益（稀释后） | $0.31 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCSSHC
| Q4 25 | $185.1M | $303.4M | ||
| Q3 25 | $168.5M | $311.3M | ||
| Q2 25 | $145.9M | $294.3M | ||
| Q1 25 | $138.3M | $254.5M | ||
| Q4 24 | $168.6M | $290.2M | ||
| Q3 24 | $136.8M | $285.5M | ||
| Q2 24 | $126.7M | $276.6M | ||
| Q1 24 | $118.1M | $248.2M |
净利润DOCSSHC
| Q4 25 | $61.6M | $34.8M | ||
| Q3 25 | $62.1M | $48.4M | ||
| Q2 25 | $53.3M | $8.0M | ||
| Q1 25 | $62.5M | $-13.3M | ||
| Q4 24 | $75.2M | $12.3M | ||
| Q3 24 | $44.2M | $17.0M | ||
| Q2 24 | $41.4M | $8.8M | ||
| Q1 24 | $40.6M | $6.3M |
毛利率DOCSSHC
| Q4 25 | 89.9% | 54.7% | ||
| Q3 25 | 90.3% | 57.0% | ||
| Q2 25 | 89.2% | 56.6% | ||
| Q1 25 | 89.5% | 53.2% | ||
| Q4 24 | 91.6% | 56.6% | ||
| Q3 24 | 90.0% | 55.4% | ||
| Q2 24 | 89.3% | 55.2% | ||
| Q1 24 | 89.4% | 51.2% |
营业利润率DOCSSHC
| Q4 25 | 38.9% | 23.2% | ||
| Q3 25 | 37.8% | 23.4% | ||
| Q2 25 | 37.4% | 6.4% | ||
| Q1 25 | 35.2% | -5.8% | ||
| Q4 24 | 47.4% | 30.0% | ||
| Q3 24 | 38.8% | 28.2% | ||
| Q2 24 | 36.4% | 27.8% | ||
| Q1 24 | 35.5% | 21.4% |
净利率DOCSSHC
| Q4 25 | 33.3% | 11.5% | ||
| Q3 25 | 36.8% | 15.5% | ||
| Q2 25 | 36.5% | 2.7% | ||
| Q1 25 | 45.2% | -5.2% | ||
| Q4 24 | 44.6% | 4.2% | ||
| Q3 24 | 32.3% | 6.0% | ||
| Q2 24 | 32.7% | 3.2% | ||
| Q1 24 | 34.4% | 2.5% |
每股收益（稀释后）DOCSSHC
| Q4 25 | $0.31 | $0.12 | ||
| Q3 25 | $0.31 | $0.17 | ||
| Q2 25 | $0.27 | $0.03 | ||
| Q1 25 | $0.31 | $-0.05 | ||
| Q4 24 | $0.37 | $0.05 | ||
| Q3 24 | $0.22 | $0.06 | ||
| Q2 24 | $0.21 | $0.03 | ||
| Q1 24 | $0.20 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $64.8M | $344.6M |
| 总债务越低越好 | — | $2.1B |
| 股东权益账面价值 | $979.3M | $606.0M |
| 总资产 | $1.2B | $3.3B |
| 负债/权益比越低杠杆越低 | — | 3.53× |
8季度趋势，按日历期对齐
现金及短期投资DOCSSHC
| Q4 25 | $64.8M | $344.6M | ||
| Q3 25 | $169.2M | $299.2M | ||
| Q2 25 | $137.3M | $332.4M | ||
| Q1 25 | $209.6M | $304.4M | ||
| Q4 24 | $165.3M | $277.2M | ||
| Q3 24 | $184.2M | $306.7M | ||
| Q2 24 | $111.4M | $246.1M | ||
| Q1 24 | $96.8M | $261.1M |
总债务DOCSSHC
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $2.2B |
股东权益DOCSSHC
| Q4 25 | $979.3M | $606.0M | ||
| Q3 25 | $1.1B | $550.5M | ||
| Q2 25 | $1.0B | $511.3M | ||
| Q1 25 | $1.1B | $414.1M | ||
| Q4 24 | $1.0B | $404.9M | ||
| Q3 24 | $961.2M | $470.2M | ||
| Q2 24 | $913.6M | $422.8M | ||
| Q1 24 | $901.4M | $429.4M |
总资产DOCSSHC
| Q4 25 | $1.2B | $3.3B | ||
| Q3 25 | $1.3B | $3.2B | ||
| Q2 25 | $1.2B | $3.2B | ||
| Q1 25 | $1.3B | $3.1B | ||
| Q4 24 | $1.2B | $3.1B | ||
| Q3 24 | $1.1B | $3.1B | ||
| Q2 24 | $1.1B | $3.1B | ||
| Q1 24 | $1.1B | $3.1B |
负债/权益比DOCSSHC
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 3.89× | ||
| Q2 25 | — | 4.34× | ||
| Q1 25 | — | 5.36× | ||
| Q4 24 | — | 5.49× | ||
| Q3 24 | — | 4.73× | ||
| Q2 24 | — | 5.26× | ||
| Q1 24 | — | 5.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.9M | $103.1M |
| 自由现金流经营现金流 - 资本支出 | — | $52.4M |
| 自由现金流率自由现金流/营收 | — | 17.3% |
| 资本支出强度资本支出/营收 | — | 16.7% |
| 现金转化率经营现金流/净利润 | 0.99× | 2.96× |
| 过去12个月自由现金流最近4个季度 | — | $149.2M |
8季度趋势，按日历期对齐
经营现金流DOCSSHC
| Q4 25 | $60.9M | $103.1M | ||
| Q3 25 | $93.9M | $71.2M | ||
| Q2 25 | $62.1M | $57.4M | ||
| Q1 25 | $98.5M | $55.5M | ||
| Q4 24 | $65.2M | $55.7M | ||
| Q3 24 | $68.3M | $97.5M | ||
| Q2 24 | $41.2M | $61.3M | ||
| Q1 24 | $63.9M | $9.7M |
自由现金流DOCSSHC
| Q4 25 | — | $52.4M | ||
| Q3 25 | — | $35.0M | ||
| Q2 25 | — | $26.2M | ||
| Q1 25 | — | $35.6M | ||
| Q4 24 | — | $-10.2M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $19.4M | ||
| Q1 24 | — | $-25.2M |
自由现金流率DOCSSHC
| Q4 25 | — | 17.3% | ||
| Q3 25 | — | 11.2% | ||
| Q2 25 | — | 8.9% | ||
| Q1 25 | — | 14.0% | ||
| Q4 24 | — | -3.5% | ||
| Q3 24 | — | 21.4% | ||
| Q2 24 | — | 7.0% | ||
| Q1 24 | — | -10.2% |
资本支出强度DOCSSHC
| Q4 25 | — | 16.7% | ||
| Q3 25 | — | 11.6% | ||
| Q2 25 | — | 10.6% | ||
| Q1 25 | 0.0% | 7.8% | ||
| Q4 24 | 0.0% | 22.7% | ||
| Q3 24 | 0.0% | 12.7% | ||
| Q2 24 | 0.0% | 15.2% | ||
| Q1 24 | 0.0% | 14.1% |
现金转化率DOCSSHC
| Q4 25 | 0.99× | 2.96× | ||
| Q3 25 | 1.51× | 1.47× | ||
| Q2 25 | 1.16× | 7.21× | ||
| Q1 25 | 1.58× | — | ||
| Q4 24 | 0.87× | 4.52× | ||
| Q3 24 | 1.55× | 5.73× | ||
| Q2 24 | 1.00× | 7.00× | ||
| Q1 24 | 1.57× | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCS
| Subscription | $175.4M | 95% |
| Service Other | $9.7M | 5% |
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
